BACKGROUND: Tay-Sachs disease (TSD) is an inherited neurodegenerative disorder caused by a lysosomal β-hexosaminidase A deficiency due to mutations in the HEXA gene. The late-onset form of disease (LOTS) is considered rare, and only a limited number of cases have been reported. The clinical course of LOTS differs substantially from classic infantile TSD. METHODS: Comprehensive data from 14 Czech patients with LOTS were collated, including results of enzyme assays and genetic analyses. RESULTS: 14 patients (9 females, 5 males) with LOTS were diagnosed between 2002 and 2018 in the Czech Republic (a calculated birth prevalence of 1 per 325,175 live births). The median age of first symptoms was 21 years (range 10-33 years), and the median diagnostic delay was 10.5 years (range 0-29 years). The main clinical symptoms at the time of manifestation were stammering or slurred speech, proximal weakness of the lower extremities due to anterior horn cell neuronopathy, signs of neo- and paleocerebellar dysfunction and/or psychiatric disorders. Cerebellar atrophy detected through brain MRI was a common finding. Residual enzyme activity was 1.8-4.1% of controls. All patients carried the typical LOTS-associated c.805G>A (p.Gly269Ser) mutation on at least one allele, while a novel point mutation, c.754C>T (p.Arg252Cys) was found in two siblings. CONCLUSION: LOTS seems to be an underdiagnosed cause of progressive distal motor neuron disease, with variably expressed cerebellar impairment and psychiatric symptomatology in our group of adolescent and adult patients. The enzyme assay of β-hexosaminidase A in serum/plasma is a rapid and reliable tool to verify clinical suspicions.

Department of Biology and Medical Genetics 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Neurology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Neurology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Paediatric Neurology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Paediatrics and Adolescent Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Ke Karlovu 2 120 00 Prague 2 Czech Republic

See more in PubMed

Eur J Pediatr. 2000 Dec;159 Suppl 3:S192-5 PubMed

Isr Med Assoc J. 2004 Feb;6(2):107-11 PubMed

Genet Med. 2005 Feb;7(2):119-23 PubMed

Genet Med. 2009 Jun;11(6):425-33 PubMed

Hum Mutat. 2010 Nov;31(11):1240-50 PubMed

Surv Ophthalmol. 2014 Jan-Feb;59(1):64-76 PubMed

Science. 1989 Mar 17;243(4897):1471-4 PubMed

Orphanet J Rare Dis. 2015 Apr 17;10:45 PubMed

Br J Psychiatry. 1989 Sep;155:410-3 PubMed

BMJ Case Rep. 2016 Mar 31;2016: PubMed

Pract Neurol. 2017 Oct;17(5):396-399 PubMed

JIMD Rep. 2018;41:17-23 PubMed

Am J Med Genet. 1986 May;24(1):179-96 PubMed

Neurology. 1979 Jun;29(6):848-54 PubMed

JAMA. 1993 Nov 17;270(19):2307-15 PubMed

J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):10-9 PubMed

Quantitative brain morphometry identifies cerebellar, cortical, and subcortical gray and white matter atrophy in late-onset Tay-Sachs disease

Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease